Background Fatherhood status has been hypothesized to affect prostate cancer risk but the current evidence is limited and contradictory.
Introduction
Prostate cancer is the second leading cause of cancer-related death in the USA with an estimated 30 000 deaths annually and more than 200 000 cases diagnosed. 1 Age, family history and geographic and ethnic origins are all established risk factors for prostate cancer. Recently, several groups have explored whether fatherhood status is an independent risk factor for prostate cancer with varied results.
A Swedish case-control study and a Danish cohort study both showed that childless men had a lower risk of prostate cancer compared with fathers, hypothesizing that androgen status may explain the relationship. 4, 7 To explain the association, these groups suggested that some men with lower offspring numbers might have impaired fertility. Although male infertility is pathologically heterogeneous, in general there is a degree of testicular failure with impaired exocrine and endocrine functions. As prostate cancer is thought to be testosterone dependent, these groups suggested that men with fewer offspring would be at a lower androgen state and have a lower risk of prostate carcinogenesis. 8 In contrast to the androgen hypothesis, the Danish cohort study and an Israeli cohort study both found that the risk of prostate cancer declined with increasing numbers of offspring among men with at least one child. 2, 7 Moreover, the Israeli study showed that fathers who were unable to sire sons had an increased risk of prostate cancer, suggesting that the gender of offspring is also predictive of prostate cancer risk. 2 Other studies, and the most recent systematic review on the subject, have failed to show an association between fatherhood and prostate cancer risk. 5, 9, 10 It is unknown whether the effects noted in the European studies are applicable in a US population, given the differences in prostate-specific antigen (PSA) screening and prostate cancer incidence that exist between the regions. 1, 11, 12 Given the prevalence of PSA screening in the USA and the attenuating effects PSA screening can have on the associations between genetic and dietary risk factors and prostate cancer, accounting for prostate cancer screening may be important when searching for links between prostate cancer and fatherhood. 13 To date, no large US study has examined the association between fatherhood status and the development of prostate cancer. In addition, individual pathologic data to establish separate cancer risks based on fatherhood status for low-and high-grade prostate cancer, as well as prostate-cancer-specific mortality are lacking.
Methods

Study population
In 1995-96, 3.5 million members of the AARP (formerly known as American Association of Retired Persons) aged 50-71 years living in one of six states (California, Florida, Louisiana, New Jersey, North Carolina and Pennsylvania) or two metropolitan areas (Atlanta, GA, and Detroit, MI) were mailed a questionnaire detailing medical history and lifestyle characteristics to initiate the NIH-AARP (National Institues of HealthAmerican Association of Retired Persons) Diet and Health Study.
14 In all, 567 169 (16.2%) respondents satisfactorily completed the initial survey. In late 1996, a supplementary survey was mailed to those participants who had successfully completed the baseline survey and did not have prostate, breast or colon cancer at baseline. The additional questionnaire asked questions regarding number of offspring and prostate cancer screening history. The NIH-AARP Diet and Health study was reviewed and approved by the Special Studies Institutional Review Board of the US National Cancer Institute (NCI).
Among the 334 908 individuals who responded to the supplemental questionnaire, we excluded women (n ¼ 138 057), those who had the survey filled out by a proxy (n ¼ 3967), men who had previously been diagnosed with cancer other than non-melanoma skin cancer (n ¼ 10 040), men with no follow-up (n ¼ 4) and men with missing offspring data (n ¼ 15 339). In addition, men who had never been married (n ¼ 5678) were excluded as reproductive opportunities of such men were difficult to assess. After these exclusions, there were a total of 161 823 men available for analysis. 
Identification of incident prostate cancer cases and deaths
Assessment of offspring number
Information on offspring number was assessed by self-report. The survey asked: 'How many sons do you have, both living and deceased? Include blood relatives only' and 'How many daughters do you have, both living and deceased? Include blood relatives only.' Total offspring number was generated by summing the results of total sons and daughters. We collapsed those with four or more offspring into one category to ensure adequate statistical power.
Statistical analysis
Each participant accrued follow-up time from the date the supplementary questionnaire was returned until prostate cancer diagnosis, death, move out of registry ascertainment area or end of study period, 31 December 2003 (for incident prostate cancer analysis) or 31 December 2005 (for fatal prostate cancer analysis). Cox proportional hazards regression was used to estimate the relation between offspring number and prostate cancer incidence and mortality. 16 The proportional hazards assumption was assessed using log minus log plots and the Schoenfeld test and upheld for all analyses. 17 Covariates were selected for inclusion in our a priori model that have been consistently shown in the literature to affect prostate cancer risk or offspring number. All multivariate models were adjusted for age, race, body mass index (BMI), marital status, educational attainment, smoking status, family history of prostate cancer and a personal history of digital rectal examination (DRE) or PSA prostate cancer screening. Tests for trend were performed by treating offspring number as a continuous variable in the Cox regression model after replacing each category (i.e. 0, 1, 2, 3, 54) with the mean of the original variable. Effect modification was assessed using the likelihood ratio test by entering fatherhood along with the covariate of interest as well as the term for their product in the multivariable model. In addition, stratified analyses were also performed to judge effect modification. All statistical tests were two sided. STATA 10 (Statacorp, College Station, TX) was used for all analyses.
Results
During 1 093 365 person-years of follow up, 8134 men with incident prostate cancer were diagnosed. Of these, 6346 men had low-grade prostate cancer and 1322 men had high-grade disease. There were 296 prostate cancer deaths from 1996 until 2005. The mean age of participants was 63 years and the mean number of offspring was 2.6-1.3 sons and 1.3 daughters. Men with more offspring tended to be older, have lower educational attainment, have a higher BMI and be non-White. In addition, a history of prostate cancer screening (both DRE or PSA) was more common for fathers than childless men. For example, fathers were more likely to have undergone PSA screening within the 3 years prior to study enrolment (78.0%) compared with childless men (75.3%, Table 1 ).
In order to determine if fatherhood status affects a man's risk of prostate cancer, childless men were compared with men with at least one child. Men without children had a similar risk of prostate cancer to fathers [hazard ratio (HR) 0.94, 95% confidence interval (CI) 0.86-1.02]. However, after stratifying based on PSA screening history (P for interaction between fatherhood and PSA screening <0.01), there was a lower risk of prostate cancer among childless men compared with fathers in the unscreened population (HR 0.73, 95% CI 0.59-0.92; Table 2 ). Although fathering at least one child was associated with a man's diagnosis of prostate cancer, the number of children fathered by men did not affect a man's risk of prostate cancer (P trend ¼ 0.17, Table 2 ). An attempt to further examine reproductive intent and opportunity by stratifying based on current marital status did not materially change the conclusions.
The association between fatherhood and prostate cancer was next assessed after stratifying prostate cancer into low grade, high grade and fatal disease. A trend for lower risk of prostate cancer among PSA The effect of offspring gender upon the relationship between fatherhood and prostate cancer was also studied among men with at least one child. Stratifying the analyses by number of children showed that as the number of total offspring rises, a father's inability to sire female offspring is associated with an increase in risk of prostate cancer in unscreened men (Table 4) . However, there was no significant difference in the secondary gender ratio (sons : total offspring) between men who developed prostate cancer (51.4%, 95% CI 50.8-52.0) and those who did not (51.0%, 95% CI 50.8-51.1; P ¼ 0.18).
Discussion
The current study found a lower risk of prostate cancer in childless men compared with fathers, whereas the risk of prostate cancer did not appear to vary with the total number of children sired. In addition, as the number of total offspring rose, a father's inability to sire female offspring was associated with an increased risk of prostate cancer. Interestingly, the association between fatherhood and prostate cancer is only seen in men who did Results are listed for all prostate cancers, low-grade prostate cancers, high-grade prostate cancers and fatal prostate cancers. Given the significant interaction between fatherhood and PSA screening (P < 0.01), stratified analyses by prostate cancer screening are listed. Cases signify the number of prostate cancer cases used in each analysis. All analyses adjusted for age, education, race, marital status, DRE screening, BMI, smoking status and family history of prostate cancer. 4 In a similar fashion, Jorgensen et al. showed that childless men had a 16% reduced risk of prostate cancer compared with fathers in Denmark. 3 Walsh and colleagues examined a man's reproductive potential without examining fatherhood status and found that men diagnosed with male factor infertility had an increased risk of high-grade prostate cancer. 18 It is also important to note that the cohort analysed by Walsh and colleagues included only men from couples evaluated for infertility and included younger men than the current report (410 years on average).
In addition, the relationship between secondary sex ratio and prostate cancer varies between countries. Although Denmark and Sweden show no alteration in the gender of offspring fathered by men with prostate cancer, 3, 4 Israeli men who develop prostate cancer have an impaired ability sire sons. 2 Harlap et al. postulated that such a finding was consistent with abnormalities on the Y chromosome, which could both harbour prostate cancer risk and impair a man's ability to produce male heirs. In contrast, the current study found that the inability to sire daughters increased a man's prostate cancer risk. Although the findings resulting from a subgroup analysis of PSA unscreened men may have resulted from chance, the inverse finding of a lower risk of prostate cancer in men unable to sire a male heir suggest that the X chromosome may be important for prostate cancer in the USA. Indeed, the X chromosome has been linked to prostate carcinogenesis containing the gene for the androgen receptor among other loci implicated in prostate cancer. [19] [20] [21] The aetiology for the association between offspring number and prostate cancer risk remains speculative. Both the Swedish and Danish groups posit androgen status mediating the link between fatherhood and prostate cancer risk. 3, 4 Indeed, the prostate is known to be a hormonally regulated with the thought that carcinogenesis is also androgen dependent. 8 Although a clear link between testosterone levels and prostate malignancy currently does not exist, 22 it is possible that androgen production or altered androgen sensitivity could provide the link between fatherhood status and prostate cancer. In the current report, some percentage of the group of childless men will be comprised of men that are unable to reproduce. Indeed, in the 2002 National Survey of Family For the analyses examining daughters, the reference group is men who sired at least one daughter compared with men with no female offspring. For the analyses examining sons, the reference group is men who sired at least one son. Given the significant interaction between fatherhood and PSA screening (P < 0.01), stratified analyses by prostate cancer screening are listed. Cases signify the number of prostate cancer cases used in each analysis. All analyses adjusted for age, education, race, marital status, DRE screening, BMI, smoking status and family history of prostate cancer.
Growth, 75% of childless, married men of reproductive age in the USA reported a desire for offspring, suggesting that impaired fertility may play a role in preventing fatherhood status in some portion of this demographic group. 23 Although pathologically heterogeneous, male infertility usually consists of some degree of testicular failure that may result in a lower androgen status and thus lower prostate cancer risk. Indeed, infertile men may have lower testosterone levels than their fertile counterparts. 24 Alternatively, a link between fatherhood status and prostate cancer could result from a shared environmental exposure. Investigators have suggested that endocrine disrupting environmental contaminants may simultaneously increase malignancy risk and impair male fertility. [25] [26] [27] An interaction between fatherhood and PSA screening was identified in our cohort. Indeed, our cohort had a relatively high rate of prostate cancer screening (77.6%); nearly as high as the treatment arms of the two recent randomized trials examining the mortality benefit for PSA screening (82.2-85%). 28, 29 Although fatherhood was associated with the risk of prostate cancer in unscreened men, no relationship between offspring number and prostate cancer seemed to exist for men who underwent PSA screening at least once 3 years prior to study entry.
Indeed, PSA screening is known to attenuate the associations between genetic and dietary risk factors and prostate cancer. 13 Giovannucci argued convincingly about the contaminating effects that the current PSA screening practices may have on the incident prostate cancer endpoint when attempting to elucidate the actions of an associating factor. 30 In a screened population, a diagnosis of prostate cancer often occurs because a man happened to have a PSA screening test, which occurs equally in men both exposed and unexposed to the risk factor of interest. Thus in a screened group where both fathers and childless men are screened with PSA, screeningbased prostate cancer ascertainment can overwhelm the naturally occurring prostate cancer that may be related to fatherhood status.
To our knowledge, this report represents the first exploration of fatherhood status and prostate cancer that incorporates PSA screening into the analysis. Although the Scandinavian studies are unlikely to be affected by PSA screening practices, due to its slower adoption in that region, Israeli and US studies could be strongly influenced by screening practices. 11, 12 Any future examination of fatherhood status and offspring number should incorporate PSA screening practices.
Additional limitations warrant mention. Participants' reproductive intent, potential and ability of their partners were difficult to assess thus misclassification of exposure likely resulted across offspring categories. Men who desired no offspring and who could not sire children were jointly classified as childless. As we interpreted fecundity as a surrogate for paternity potential, such differential misclassification would likely result in regression to the null, which would be expected to lead to an underestimate of the association between fatherhood and prostate cancer found in this study. It is also conceivable that the relationship between fatherhood and cancer in unscreened men may have resulted from unmeasured confounding or chance alone. 31 Offspring number was self-reported and could be inaccurate; however, other studies have established the accuracy of self-reported reproductive histories. [32] [33] [34] Although we found no evidence of an effect modification by age, it is possible that the relationship between prostate cancer and offspring number could be different for men younger than those eligible for AARP membership. Given prostate cancer's slow growth rate, our follow-up period was relatively short. Moreover, as only 16% of those AARP members who were invited to participate ultimately returned questionnaires, volunteer bias could affect results. In addition, we were unable to account for parental age and birth order in our analysis, all of which are thought to affect the secondary sex ratio to some degree. [35] [36] [37] Importantly, there was significant effect modification between fatherhood and PSA screening with the reduced risk associated with being childless restricted to men who had no history of PSA screening. Although information regarding PSA screening 3 years prior to cohort recruitment was available, less is known about prostate cancer screening subsequently. Finally, the analyses examining high-grade and fatal prostate cancer involved few cases and have wide CIs that require careful intepretation.
Nevertheless, our study is the largest US cohort study to examine the relationship between fatherhood and prostate cancer. Our prospective design avoids the recall and selection bias inherent in case-control studies. Our high statistical power, with more than 8000 prostate cancers, and the ability to control for potential confounding demographic and lifestyle factors further strengthened our analysis.
In summary, we observed that childless men had a lower risk of prostate cancer among PSA unscreened men. Our findings suggest fatherhood status and offspring gender is associated with a man's prostate cancer risk. More studies are warranted to examine the correlation between men's reproductive history and prostate cancer risk. 
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